0
0
Kedaara Capital has invested approximately $200 million in Tynor Orthotics, acquiring a majority stake in the Indian orthopaedic support and rehabilitation products company. The deal highlights growing private-equity interest in India’s medical devices and healthcare market, while giving Tynor additional capital and strategic support to expand in India and overseas.
Founded in 1993 and headquartered in Mohali, Tynor has developed a broad portfolio covering orthopaedic supports, mobility aids, rehabilitation products and sports-performance solutions. Its products are distributed through more than 300,000 retail outlets and 8,000 hospitals across 60 countries, according to company information cited in the transaction announcement.
Kedaara Acquires Majority Stake in Tynor
Kedaara Capital has acquired approximately 51% of Tynor Orthotics in a transaction valued at around $200 million, according to The Economic Times. The investment represents a major expansion of Kedaara’s healthcare and medical-devices portfolio.
The transaction also provides an exit opportunity for existing investor Lighthouse Funds, while Tynor’s promoters and management remain involved in the business.
Kedaara will work with Tynor’s existing promoters, Dr. P.J. Singh and A.J. Singh, its professional management team and French orthopaedic company Thuasne, which has been a strategic partner of Tynor since 2010.
Why Tynor Is Attractive to Kedaara Capital
The investment reflects Kedaara’s confidence in India’s expanding medical-devices industry.
Healthcare demand is changing as India’s population becomes more health-conscious and access to medical products improves. Orthopaedic supports and rehabilitation products serve a broad range of needs, from injury recovery and sports performance to mobility assistance and post-operative care.
For Kedaara, Tynor provides exposure to a company operating at the intersection of medtech, consumer healthcare and rehabilitation.
Kedaara founder and managing partner Sunish Sharma described India’s medical-devices sector as one of the fastest-growing globally and identified Tynor as a category leader in orthopaedic supports and rehabilitation.
Tynor Has Built a Large Distribution Network
One of Tynor’s key strengths is its extensive distribution footprint.
The company says its products reach more than 300,000 retail outlets and 8,000 hospitals across 60 countries. Its products have also reached more than 100 million people, according to the company’s statement reported by The Economic Times.
This distribution network gives Tynor a significant platform from which to introduce new products and expand its presence in international markets.
The scale of its existing network is also an important factor for an investor looking to accelerate growth rather than build a distribution system from scratch.
Three Manufacturing Facilities Support Expansion
Tynor operates three manufacturing facilities, with a focus on lean manufacturing and globally compliant production capabilities.
The company has also developed manufacturing infrastructure covering approximately 6.5 lakh square feet, according to YourStory.
Kedaara’s investment is expected to support further strengthening of manufacturing capabilities as Tynor seeks to grow both domestically and internationally.
Focus on India’s Growing Medical Devices Sector
India’s medical-devices market has attracted increasing attention from investors as healthcare infrastructure expands and demand for specialized products grows.
Orthopaedic products represent an important segment because they can serve patients recovering from injuries, individuals managing mobility issues and consumers involved in sports and physical activity.
The combination of healthcare demand, manufacturing capabilities and India’s expanding middle-class consumer base provides a potentially attractive environment for companies such as Tynor.
Kedaara’s investment indicates that private-equity investors see opportunities beyond hospitals and pharmaceuticals within the broader healthcare ecosystem.
Tynor Targets a Broader Orthopaedic and Wellness Platform
The partnership is not simply focused on expanding sales of existing products.
Kedaara and Tynor plan to build a broader orthopaedic and wellness platform, while strengthening the company’s manufacturing capabilities and expanding its presence in both Indian and international markets.
This strategy could allow Tynor to move beyond its traditional orthopaedic-support business and develop a wider portfolio of products related to rehabilitation, mobility and wellness.
Such expansion could also create opportunities for the company to enter additional markets and deepen relationships with healthcare professionals.
Thuasne Remains a Strategic Partner
The transaction also retains the involvement of Thuasne, a French orthopaedic company that has worked with Tynor as a strategic partner since 2010.
The continued relationship could provide Tynor with international industry expertise and help support its ambitions outside India.
For Kedaara, maintaining relationships with the existing management and strategic partners can also provide continuity as the company begins its next phase of growth.
Private Equity Interest in Healthcare Continues
The Tynor transaction is part of a broader trend of private-equity firms increasing their exposure to India’s healthcare and medical-technology sectors.
Investors are increasingly looking at healthcare businesses with strong brands, scalable distribution networks and opportunities for expansion.
Tynor fits several of those characteristics, with an established brand, extensive distribution reach and international operations.
The $200 million investment therefore represents more than a single company transaction—it also signals confidence in India’s wider medical-devices ecosystem.
What the Deal Means for Tynor
For Tynor, the investment provides a new strategic partner and additional financial resources to accelerate its growth plans.
The company can potentially use the partnership to increase manufacturing capacity, expand its product portfolio, strengthen its domestic presence and enter new international markets.
At the same time, keeping the existing promoters and management involved should provide continuity in the company’s operations and long-term strategy.
India’s Orthopaedic Market Could See More Investment
The transaction could encourage further investment in India’s orthopaedic and medical-device sectors.
As investors search for healthcare opportunities beyond traditional pharmaceuticals and hospital chains, companies focused on medical equipment, rehabilitation and consumer health products may become increasingly attractive.
Tynor’s international reach also demonstrates that Indian medical-device companies can potentially build global businesses rather than relying exclusively on domestic demand.
Kedaara Capital’s approximately $200 million investment in Tynor Orthotics marks a significant bet on India’s growing orthopaedic and medical-devices market. Kedaara has acquired a majority stake of around 51% and plans to work with Tynor’s promoters, management team and strategic partner Thuasne to support the company’s next stage of growth.
With a distribution network spanning 300,000-plus retail outlets, 8,000 hospitals and 60 countries, Tynor already has a substantial platform for expansion
